Scoop has an Ethical Paywall
Work smarter with a Pro licence Learn More
 

Neuren Pharmaceuticals - Latest News [Page 1]

US Defense Approves Funding for NNZ-2566 Trials

Monday, 21 January 2008, 3:27 pm | Neuren Pharmaceuticals

Neuren Pharmaceuticals (ASX:NEU) today announced that the US Department of Defense (DOD) has approved a proposal by the US Army Walter Reed Army Institute of Research (WRAIR) to provide US$4 million in funding for the Company’s second lead compound ... More >>

Neuren: A$10.1m Non-renounceable Rights Issue

Wednesday, 19 December 2007, 2:10 pm | Neuren Pharmaceuticals

Neuren Pharmaceuticals Limited (ASX: NEU) advises that it will undertake a non-renounceable rights issue to raise up to A$10.1 million. More >>

 
 
 
 
 

LATEST HEADLINES

  • PARLIAMENT
  • POLITICS
  • REGIONAL
 

Join Our Free Newsletter

Subscribe to Scoop’s 'The Catch Up' our free weekly newsletter sent to your inbox every Monday with stories from across our network.